- Home
- CRGO vs IKT Comparison
CRGO vs IKT Comparison
Compare CRGO & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGO
- IKT
- Stock Information
- Founded
- CRGO 2012
- IKT 2008
- Country
- CRGO Spain
- IKT United States
- Employees
- CRGO N/A
- IKT N/A
- Industry
- CRGO Blank Checks
- IKT Biotechnology: Pharmaceutical Preparations
- Sector
- CRGO Finance
- IKT Health Care
- Exchange
- CRGO Nasdaq
- IKT Nasdaq
- Market Cap
- CRGO 118.1M
- IKT 131.6M
- IPO Year
- CRGO N/A
- IKT 2020
- Fundamental
- Price
- CRGO $2.45
- IKT $1.67
- Analyst Decision
- CRGO Buy
- IKT Buy
- Analyst Count
- CRGO 1
- IKT 2
- Target Price
- CRGO $3.50
- IKT $8.00
- AVG Volume (30 Days)
- CRGO 62.4K
- IKT 143.3K
- Earning Date
- CRGO 08-18-2025
- IKT 08-13-2025
- Dividend Yield
- CRGO N/A
- IKT N/A
- EPS Growth
- CRGO N/A
- IKT N/A
- EPS
- CRGO N/A
- IKT N/A
- Revenue
- CRGO $25,375,000.00
- IKT N/A
- Revenue This Year
- CRGO $26.97
- IKT N/A
- Revenue Next Year
- CRGO $26.11
- IKT N/A
- P/E Ratio
- CRGO N/A
- IKT N/A
- Revenue Growth
- CRGO 21.92
- IKT N/A
- 52 Week Low
- CRGO $1.27
- IKT $1.12
- 52 Week High
- CRGO $4.42
- IKT $4.20
- Technical
- Relative Strength Index (RSI)
- CRGO 57.94
- IKT 36.24
- Support Level
- CRGO $2.10
- IKT $1.56
- Resistance Level
- CRGO $2.32
- IKT $1.78
- Average True Range (ATR)
- CRGO 0.14
- IKT 0.12
- MACD
- CRGO 0.00
- IKT -0.03
- Stochastic Oscillator
- CRGO 85.37
- IKT 21.57
About CRGO Freightos Limited Ordinary shares
Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters. forwarders, and dozens of airlines and ocean carriers. WebCargo by Freightos is a freight platform connecting carriers and forwarders in particular an air cargo eBooking platform. Freightos.com is a digital international freight marketplace for importers and exporters for instant pricing, booking, and shipment management. The company operates in two segments-Platform segment and Solutions segment. Geographically, the company operates in Europe, Hong Kong, United States which is majority revenue generator and others.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.